Regulation of apoptosis by Bcl-2 cysteine oxidation in human lung epithelial cells

Molecular Biology of the Cell

Volumn 24, Issue 6, 2013, Pages 858-869

  Luanpitpong, Sudjit ^a   Chanvorachote, Pithi ^b   Stehlik, Christian ^c   Tse, William ^a   Callery, Patrick S ^a   Wang, Liying ^d   Rojanasakul, Yon ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; CYSTEINE; GLUTATHIONE; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN BCL 2; SULFENIC ACID DERIVATIVE;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG ALVEOLUS EPITHELIUM; MUTATION; OXIDATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ACETYLCYSTEINE; ANTIOXIDANTS; APOPTOSIS; CATALASE; CELL LINE; CYSTEINE; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; LUNG; MAP KINASE SIGNALING SYSTEM; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA;

EID: 84875182486     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-10-0747     Document Type: Article

References (40)

1. Azad N, Iyer AK, Manosroi A, Wang L, Rojanasakul Y (2008). Superoxidemediated proteasomal degradation of Bcl-2 determined cell susceptibility to chromium (VI)-induced apoptosis. Carcinogenesis 29, 1538-1545.
2. Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G (1994). Small cell carcinomas of the lung express the Bcl-2 protein. Am J Pathol 145, 1036-1040. (Pubitemid 24345651)
3. Chanvorachote P, Nimmanit U, Stehlik C, Wang L, Jiang B, Ongpipatanakul B, Rojanasakul Y (2006). Nitric oxide regulates cell sensitivity to cisplatininduced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res 66, 6353-6360.
4. Darnell GA, Antalis TM, Johnstone RW, Stringer BW, Ogbourne SM, Harrich D, Suhrbier (2003). Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol Cell Biol 23, 6520-6532. (Pubitemid 37075763)
5. Dimmeler S, Breitschopf K, Haendeler J, Zeiher AM (1999). Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 189, 1815-1822. (Pubitemid 29272698)
6. Forman HJ (2009). Signal transduction and reactive species. Free Radic Biol Med 47, 1237-1238.
7. Fruehauf JP, Meyskens Jr JL (2007). Reactive oxygen species: a breath of life or death? Clin Cancer Res 13, 789-794. (Pubitemid 46340350)
8. Gupta S (2003). Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol 22, 15-20.
9. Halliwell B (2007). Oxidative stress and cancer: have we moved forward? Biochem J 401, 1-11. (Pubitemid 46115897)
10. Halliwell B, Clement MV, Ramalingam J, Long LH (2000). Hydrogen peroxide. Ubiquitous in cell culture and in vivo. IUBMB Life 50, 251-257. (Pubitemid 32289082)
11. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell 100, 57-70. (Pubitemid 30046295)
12. Hancock JT, Desikan R, Neill SJ (2001). Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 29, 345-350. (Pubitemid 32587530)
13. Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J, Marrack P (2003). Control of Bcl-2 expression by reactive oxygen species. Proc Natl Acad Sci USA 100, 15035-15040. (Pubitemid 37518012)
14. Jiang SX, Sato Y, Kuwao S, Kameya T (1995). Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 177, 135-138.
15. Juan ME, Wenzel U, Daniel H, Planas JM (2008). Resveratrol induces apoptosis through ROS-dependent mitochondrial pathway in HT-29 human colorectal carcinoma cells. J Agric Food Chem 56, 4813-4818. (Pubitemid 351999415)
16. Kasibhatla S, Tseng B (2003). Why target apoptosis in cancer treatment. Mol Cancer Ther 2, 573-580.
17. Kaushal G P, Liu L, Kaushal V, Hong X, Melnyk O, Seth R, Safirstein R, Shah SV (2004). Regulation of caspase-3 and -9 activation in oxidant stress to RTE by forkhead transcription factors, Bcl-2 proteins, MAP kinases. Am J Physiol Renal Physiol 287, F1258-F1268. (Pubitemid 39507235)
18. Korsmeyer SJ, Yin XM, Oltvai ZN, Veis-Novack DJ, Linette GP (1995). Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta 1271, 63-66.
19. Luanpitpong S, Nimmannit U, Chanvorachote P, Leonard SS, Pongrakhananon V, Wang L, Rojanasakul Y (2011). Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism. Apoptosis 16, 769-782.
20. Matolcsy A, Casali P, Warnke RA, Knowles DM (1996). Morphological transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 88, 3937-3944. (Pubitemid 26383118)
21. Medan D, Luanpitpong S, Azad N, Wang L, Jiang BH, Davis ME, Barnett JB, Guo L, Rojanasakul Y (2012). Multifunctional role of Bcl-2 in malignant transformation and tumorigenesis of Cr (VI)-transformed lung cells. PLoS One 7, e37045.
22. Michalek RD, Nelson KJ, Holbrook BC, Yi JS, Stridiron D, Daniel LW, Fetrow JS, King SB, Poole LB, Grayson JM (2007). The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol 179, 6456-6467.
23. Moungjaroen J, Nimmannit U, Callery PS, Wang L, Azad N, Lipipun V, Chanvorachote P, Rojanasakul Y (2006). Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 downregulation. J Pharmacol Exp Ther 319, 1062-1069.
24. Osford SM, Dallman CL, Johnson PW, Ganesan A, Packham G (2004). Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr Med Chem 11, 1031-1039.
25. Packham G (1998). Mutation of Bcl-2 family proteins in cancer. Apoptosis 3, 75-82. (Pubitemid 128512707)
26. Reed JC, Tanaka S (1993). Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression. Leukemia Lymphoma 10, 157-163. (Pubitemid 23256587)
27. Rehder DS, Borges CR (2010). Possibilities and pitfalls in quantifying the extent of cysteine sulfenic acid modification of specific proteins with complex biofluids. BMC Biochem 11, 25.
28. Reynaert NL et al. (2006). Dynamic redox control of NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory κB kinase beta. Proc Natl Acad Sci USA 103, 13086-13091. (Pubitemid 44338920)
29. Shivapurkar N, Reddy J, Chaudharry PM, Gazdar AF (2003). Apoptosis and lung cancer: a review. J Cell Biochem 88, 885-898. (Pubitemid 36337033)
30. Thompson CB (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
31. Torres M, Forman HJ (2003). Redox signaling and the MAP kinase pathways. Biofactors 17, 287-296. (Pubitemid 37267162)
32. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J (2002). Redox control of cell death. Antioxid Redox Signal 4, 405-414. (Pubitemid 34753380)
33. Valko M, Leibfritz D, Moncol J, Cronin M T D, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44-84. (Pubitemid 44566469)
34. Van Dieck J, Teufel D P, Jaulent AM, Fernandez-Fernandez MR, Rutherford TJ, Wyslouch-Cieszynska A, Fersht AR (2009). Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53. J Mol Biol 394, 922-930.
35. Wang L, Chanvorachote P, Toledo D, Stehlik C, Mercer RR, Castranova V, Rojanasakul Y (2008). Peroxide is a key mediator of Bcl-2 downregulation and apoptosis induction by cisplatinin human lung cancer cells. Mol Pharmacol 73, 119-127. (Pubitemid 350294203)
36. Willimott S, Wagner SD (2010). Post-transcriptional and post-translational regulation of Bcl-2. Biochem Soc Trans 38, 1571-1575.
37. Yang ML, Doyle HA, Gee RJ, Lowenson JD, Clarke S, Lawson BR, Aswad DW, Mamula MJ (2006). Intracellular protein modification associated with altered T cell functions in autoimmunity. J Immunol 177, 4541-4549. (Pubitemid 44469785)
38. Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ (2012). Redox modification of cysteine residues regulates the cytokine activity of HMGB1. Mol Med 18, 250-259.
39. Zheng Y, Wang B, Jayappa KD, Yao X (2011). Host protein Ku70 binds and protects HIV-1 integrase from proteasomal degradation and is required for HIV replication. J Biol Chem 286, 17722-17735.
40. Zhuang S, Yan Y, Daubert RA, Han J, Schnellmann RG (2007). ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am J Physiol Renal Physiol 292, F440-F447. (Pubitemid 46105282)